Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous blood.

Kalweit, G A; Feindt, P; Micek, M; Gams, E; Hellstern, P

Kalweit, G A; Feindt, P; Micek, M; Gams, E; Hellstern, P.

Affiliation

Kalweit GA; Department of Cardio-Thoracic Surgery, Heinrich Heine University, Düsseldorf, Germany.

Thromb Res ; 97(3): 105-11, 2000 Feb 01.

Article in En | MEDLINE | ID: mdl-10680641

Subject(s)

Fibrinolysis/physiology; Hemostasis/physiology; Lung Neoplasms/blood; Aged; Antifibrinolytic Agents/blood; Antithrombin III/analysis; Biomarkers/blood; Blood Coagulation; Female; Fibrin Fibrinogen Degradation Products/analysis; Humans; Lung Neoplasms/mortality; Male; Middle Aged; Peptide Fragments/analysis; Peptide Hydrolases/analysis; Pneumonectomy; Protein Precursors/analysis; Prothrombin/analysis; Pulmonary Veins/chemistry; Pulmonary Veins/physiology; Survival Rate; Thrombophilia; Vena Cava, Superior/chemistry

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Fibrinolysis / Hemostasis / Lung Neoplasms Type of study: Observational_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2000 Type: Article

Search on Google

XML

PubMed Links